These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7623733)
21. Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial. Schrappe M Lancet; 2010 Dec; 376(9757):1968-70. PubMed ID: 21131040 [No Abstract] [Full Text] [Related]
22. Orbital Mass in a Child With Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature. Ramamoorthy J; Jain R; Trehan A; Saxena AK; Ahluwalia J J Pediatr Hematol Oncol; 2016 Nov; 38(8):646-648. PubMed ID: 26925710 [TBL] [Abstract][Full Text] [Related]
24. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481 [TBL] [Abstract][Full Text] [Related]
25. Pegaspargase for acute lymphoblastic leukemia. Med Lett Drugs Ther; 1995 Mar; 37(944):23-4. PubMed ID: 7877556 [No Abstract] [Full Text] [Related]
26. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia. Tomar S; Bakhshi S; Kabra SK; Arya LS Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625 [No Abstract] [Full Text] [Related]
27. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol]. Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045 [No Abstract] [Full Text] [Related]
28. [High-risk acute lymphoblastic leukemia]. Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041 [No Abstract] [Full Text] [Related]
29. The role of bortezomib in the treatment of acute lymphoblastic leukemia. Zahid MF Future Oncol; 2016 Aug; 12(16):1861-4. PubMed ID: 27173950 [No Abstract] [Full Text] [Related]
30. [Progress in researches on L-asparaginase targeted to childhood leukemia]. Cui YQ; Chen FX; Wu ZL Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):227-30. PubMed ID: 15144726 [No Abstract] [Full Text] [Related]
31. The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia. Estlin EJ; Ronghe M; Burke GA; Yule SM Br J Haematol; 2000 Sep; 110(4):780-90. PubMed ID: 11054059 [No Abstract] [Full Text] [Related]
33. Building better therapy for children with acute lymphoblastic leukemia. Carroll WL; Raetz EA Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616 [TBL] [Abstract][Full Text] [Related]
34. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia. Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644 [No Abstract] [Full Text] [Related]
35. Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Mann G; Steiner M; Attarbaschi A Leuk Lymphoma; 2007 May; 48(5):849-50. PubMed ID: 17487724 [No Abstract] [Full Text] [Related]